| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | - | 0 | 0 | 0 | 1 | 0 | - | - | - | - |
| Total Expenses - EUR | - | 119 | 1.630 | 1.452 | 1.101 | 863 | - | - | - | - |
| Gross Profit/Loss - EUR | - | -119 | -1.630 | -1.452 | -1.099 | -863 | - | - | - | - |
| Net Profit/Loss - EUR | - | -119 | -1.630 | -1.452 | -1.099 | -863 | - | - | - | - |
| Employees | - | 0 | 0 | 1 | 1 | 1 | - | - | - | - |
Check the financial reports for the company - Immunity Plus Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 958 | 851 | 748 | 692 | 639 | - | - | - | - |
| Current Assets | - | 411 | 36 | 292 | 300 | 210 | - | - | - | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | - | 0 | 0 | 283 | 205 | 201 | - | - | - | - |
| Cash | - | 411 | 36 | 9 | 95 | 9 | - | - | - | - |
| Shareholders Funds | - | 326 | -1.309 | -2.736 | -3.783 | -4.573 | - | - | - | - |
| Social Capital | - | 445 | 438 | 430 | 421 | 413 | - | - | - | - |
| Debts | - | 1.042 | 2.196 | 3.776 | 4.775 | 5.423 | - | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Immunity Plus Lab Srl